Literature DB >> 19576496

Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis.

Lawrence W Hirst1.   

Abstract

OBJECTIVE: To assess the rate of recurrence, complications, and cosmesis after recurrent pterygium removal with P.E.R.F.E.C.T. for PTERYGIUM (Pterygium Extended Removal Followed by Extended Conjunctival Transplant).
DESIGN: A case series study of P.E.R.F.E.C.T. for PTERYGIUM was conducted by 1 surgeon with a 1-year follow-up to assess the recurrence, complication rate, and cosmesis. PARTICIPANTS: A total of 111 consecutive patients with recurrent pterygium removals. INTERVENTION: A major modification of conjunctival autograft surgery was used to treat recurrent pterygia. MAIN OUTCOME MEASURES: The recurrence rate, complications, and cosmesis after excision of recurrent pterygia using P.E.R.F.E.C.T. for PTERYGIUM.
RESULTS: There were no patients with recurrence in 111 consecutive patients, and all but 2 patients were followed for at least 1 year. One patient developed an exotropia that required no treatment, and 1 patient lost 4 lines of vision as a result of a corneal ulcer.
CONCLUSIONS: In this series, P.E.R.F.E.C.T. for PTERYGIUM resulted in a zero recurrence rate (2 patients lost to follow-up) with few complications and a good cosmetic appearance.

Entities:  

Mesh:

Year:  2009        PMID: 19576496     DOI: 10.1016/j.ophtha.2009.01.044

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

Review 1.  Conjunctival Autograft Versus Amniotic Membrane Transplantation for Treatment of Pterygium: Findings From a Cochrane Systematic Review.

Authors:  Elizabeth Clearfield; Barbara S Hawkins; Irene C Kuo
Journal:  Am J Ophthalmol       Date:  2017-07-19       Impact factor: 5.258

2.  Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium.

Authors:  Takashi Ono; Yosai Mori; Ryohei Nejima; Tadatoshi Tokunaga; Kazunori Miyata; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-26       Impact factor: 3.117

3.  Dysregulated heme oxygenase-ferritin system in pterygium pathogenesis.

Authors:  Timothy Fox; Katherine H Gotlinger; Michael W Dunn; Olivia L Lee; Tatyana Milman; Gerald Zaidman; Michal L Schwartzman; Lars Bellner
Journal:  Cornea       Date:  2013-09       Impact factor: 2.651

4.  Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial.

Authors:  Rongxin Chen; Guofu Huang; Shu Liu; Wenfang Ma; Xiaofang Yin; Shiyou Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-20       Impact factor: 3.117

5.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

Review 6.  Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery.

Authors:  Vito Romano; Mario Cruciani; Luigi Conti; Luigi Fontana
Journal:  Cochrane Database Syst Rev       Date:  2016-12-02

7.  Ophthalmic transplantology: anterior segment of the eye - part I.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-05

8.  Evaluation of Primary Pterygia on Basis of the Loss of Vertical Length of Plica Semilunaris.

Authors:  Minjeong Kim; Yeoun Sook Chun; Kyoung Woo Kim
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.283

9.  Management of complicated multirecurrent pterygia using multimicroporous expanded polytetrafluoroethylene.

Authors:  Kyoung Woo Kim; Jae Chan Kim; Jun Hyung Moon; Hyun Koo; Tae Hyung Kim; Nam Ju Moon
Journal:  Br J Ophthalmol       Date:  2013-03-15       Impact factor: 4.638

10.  Pre- and intraoperative mitomycin C for recurrent pterygium associated with symblepharon.

Authors:  Isyaku Mohammed
Journal:  Clin Ophthalmol       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.